These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2649149)

  • 21. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
    Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
    Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the effect of carbomer-, cellulose- and mineral oil-based artificial tear formulations.
    Wang IJ; Lin IC; Hou YC; Hu FR
    Eur J Ophthalmol; 2007; 17(2):151-9. PubMed ID: 17415686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hydroxypropylmethyl-containing eyedrops in the treatment of sicca syndrome].
    Török M
    Klin Monbl Augenheilkd; 1985 Jul; 187(1):60-2. PubMed ID: 4068574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of inserts in the treatment of dry eye syndromes (preliminary results)].
    Huguet P; Colin J; Renard G
    Bull Soc Ophtalmol Fr; 1981 Dec; 81(12):1173-7. PubMed ID: 7343154
    [No Abstract]   [Full Text] [Related]  

  • 25. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tarsorrhaphy for corneal disease in patients with rheumatoid arthritis.
    Welch C; Baum J
    Ophthalmic Surg; 1988 Jan; 19(1):31-2. PubMed ID: 3340399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sicca symptoms, and lacrimal and salivary flow in Albanian patients with rheumatoid arthritis.
    Aliko A; Ciancaglini R; Alushi A; Tafaj A
    J Oral Pathol Med; 2010 Sep; 39(8):651-6. PubMed ID: 20456616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimising tear replacement rheology in canine keratoconjunctivitis sicca.
    Williams DL
    Eye (Lond); 2018 Feb; 32(2):195-199. PubMed ID: 29303147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Keratoconjunctivitis sicca in rheumatoid arthritis: correlation with the autoantibody pattern].
    Altomonte L; Zoli A; Galossi A; Mirone L; Scuderi F; Magarò M
    Ann Ital Med Int; 1995; 10(2):103-6. PubMed ID: 7619648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
    Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
    Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ocular involvement and its' manifestations in rheumatoid arthritis patients].
    Markovitz E; Perry ZH; Tsumi E; Abu-Shakra M
    Harefuah; 2011 Sep; 150(9):713-8, 751. PubMed ID: 22026055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alginate inserts loaded with epidermal growth factor for the treatment of keratoconjunctivitis sicca.
    Koelwel C; Rothschenk S; Fuchs-Koelwel B; Gabler B; Lohmann C; Gopferich A
    Pharm Dev Technol; 2008; 13(3):221-31. PubMed ID: 18484491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Our further experience with bromhexine in keratoconjunctivitis sicca.
    Avisar R; Savir H
    Ann Ophthalmol; 1988 Oct; 20(10):382. PubMed ID: 3207309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term use of hydroxypropyl cellulose ophthalmic insert to relieve symptoms of dry eye in a contact lens wearer: case-based experience.
    Wander AH
    Eye Contact Lens; 2011 Jan; 37(1):39-44. PubMed ID: 21178699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
    Arimoto A; Kitagawa K; Mita N; Takahashi Y; Shibuya E; Sasaki H
    Cornea; 2014 Aug; 33(8):806-11. PubMed ID: 24977983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lacrimal immunoglobulins in rheumatoid arthritis patients with or without Sjögren's syndrome.
    Domingo I; Coll J; Ribas-Montobio J; Marrugat J; Rubiés-Prat J
    Ophthalmologica; 1998; 212(1):30-3. PubMed ID: 9438581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of ocular complications in rheumatoid arthritis and the relation of keratoconjunctivitis sicca with its systemic activity.
    Matsuo T; Kono R; Matsuo N; Ezawa K; Natsumeda M; Soda K; Ezawa H
    Scand J Rheumatol; 1997; 26(2):113-6. PubMed ID: 9137326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Eledoisin eyedrops in the therapy of keratoconjunctivitis sicca].
    Spinelli D; Trabucchi P; Formenti F
    Ophtalmologie; 1988; 2(2):145-7. PubMed ID: 3247153
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca.
    Solomon A; Merin S
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):497-504. PubMed ID: 9867333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.